Blue Fin Vision founder Mr Mfazo Hove will be attending the European Society of Cataract and Refractive Surgeons (ESCRS) 2025 Congress in Barcelona, presenting audited outcomes from 50,000+ procedures, and showcased ZEISS IOL innovations, AI-driven diagnostics, and personalised workflows.
-- Blue Fine Vision, one of Britain’s most awarded eye surgery clinics, has announced that its founder and lead surgeon, Mr. Mfazo Hove, was invited by global optics leader ZEISS to present at the European Society of Cataract and Refractive Surgeons (ESCRS) 2025 Congress in Barcelona.
Mr Hove’s session will provide real-world data on ZEISS toric, multifocal, and trifocal intraocular lenses (IOLs), showcasing audited results from over 50,000 procedures. His presentation draws attention to the synergy between AI-powered diagnostics, premium lens technology, and personalised surgical workflows, positioning Blue Fin Vision at the forefront of global ophthalmic innovation.
Blue Fin Vision®’s milestone collaboration with ZEISS follows BFV’s recent recognition in Spear’s 2025 Health & Wellness Index, where Mr Hove was named the UK’s highest-ranked ophthalmologist.
About The ESCRS Congress
Considered by many in the industry to be the leader in professional advancement and networking in the cataract and refractive surgery field, this year’s ESCRS Congress takes place at the state-of-the-art Bella Centre in Copenhagen, Denmark, from 12–16 September 2025. More than 15,000 delegates are expected to attend an event of pioneering science, hands-on workshops, and influential discussions to shape the future of ophthalmology.
Mr Hove has been selected by ZEISS – one of the foremost names in medical optics – to present cutting-edge clinical updates on ZEISS intraocular lenses (IOLs). His session, offering direct evidence and first-hand clinical analysis from recent research, is sure to capture the attention of peers from across the globe.
Blue Fin Vision’s Collaboration With ZEISS
ZEISS is a leading developer of intraocular lenses, having worked with Blue Fin Vision to push the boundaries of surgical possibilities. The team at Blue Fin uses them to tailor each procedure with improved levels of precision and predictability.
ZEISS’s selection of Blue Fin Vision for ESCRS showcases the team’s collaborative efforts at the highest level, as Blue Fin brings the experience to be able to explain the technological advancements behind ZEISS Premium Cataract Workflow, enabling seamless integration from diagnosis to optimal post-operative results. They will also explore real-world outcomes using ZEISS toric, multifocal, and trifocal lenses, with a particular focus on reducing post-operative astigmatism and enhancing refractive accuracy.
It is a point of great pride that Mr Hove represents both Blue Fin Vision and the United Kingdom at this world stage. Sharing his knowledge, research, and personal experience in collaboration with ZEISS, whose technology is integral to our practice, reflects the continuing advancement and knowledge transfer that defines our philosophy.
For more information about Blue Fin Vision, use the contact details below.
Contact Info:
Name: Mfazo Hove
Email: Send Email
Organization: Blue Fin Vision
Phone: 07704225640
Website: https://bluefinvision.com
Release ID: 89169043
If there are any problems, discrepancies, or queries related to the content presented in this press release, we kindly ask that you notify us immediately at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be available round-the-clock to address your concerns within 8 hours and take necessary actions to rectify any identified issues or support you with press release takedowns. Ensuring accurate and trustworthy information is our unwavering commitment.
